<!-- cyrus.html -->
<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
  <title>Dr. Cyrus Hsia</title>
  <link rel="stylesheet" href="style.css" />
</head>
<body>
  <header>
    <nav>
      <a href="index.html">About</a>
      <a href="team.html">Team</a>
      <a href="publications.html">Publications</a>
      <a href="news.html">News</a>
      <a href="contact.html">Contact</a>
    </nav>
  </header>

  <main>
    <section class="profile-page">
      <h1>Dr. Cyrus Hsia</h1>
      <img src="images/CyrusProfilePic.png" alt="Dr. Cyrus Hsia" class="profile-pic" />
      <h2>Role</h2>
      <p>Dr. Cyrus Hsia is an Associate Professor in the Division of Hematology, Department of Medicine at the Schulich School of Medicine & Dentistry, Western University, and a Consultant Hematologist at London Health Sciences Centre. He also serves as Program Director for the Adult Hematology Residency Training Program and Associate Medical Director of the Transfusion Medicine Laboratories.
</p>
      <h2>Education</h2>
      </li>Dr. Hsia completed his undergraduate degrees in Mathematics and Human Biology at the University of Toronto. He 
        attended medical school at the University of Western Ontario (Schulich School of Medicine & Dentistry) and completed his Internal Medicine residency and fellowship training 
        in Hematology at UWO as well. 
         </li>

      <h2>Research Interests</h2>
        </li>His work focuses on bleeding and clotting disorders, transfusion medicine, hematologic malignancies, and clinical decision-making in hematology. He has published extensively on immune thrombocytopenia, myelodysplastic syndromes, erythrocytosis, and the implementation of next-generation sequencing in clinical hematology.</li>

      <h2>Current Projects</h2>
    </li> Dr. Hsia is actively involved in clinical trials and translational research, including studies on perioperative management of immune thrombocytopenia, optimizing transfusion practices, the role of next-generation sequencing in hematologic cancers, and the clinical utility of novel molecular diagnostics. He also supervises resident and student projects spanning thrombosis, hemoglobinopathies, and myeloid neoplasms, contributing to the advancement of evidence-based hematology. </li>
    
    </section>
  </main>

  <footer>
    <p>Â© 2025 Our Research Lab</p>
  </footer>
</body>
</html>
